(Q34768553)

4 August 2017

1 reference

title

Cytokine modulation in sepsis and septic shock (English)

1 reference

4 August 2017

0 references

1 reference

Sergio Zanotti

1

1 reference

4 August 2017

Aseem Kumar

series ordinal

2

1 reference

4 August 2017

Anand Kumar

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Expert Opinion on Investigational Drugs

4 August 2017

1 reference

4 August 2017

11

1 reference

4 August 2017

1061-1075

1 reference

4 August 2017

8

1 reference

Has the mortality of septic shock changed with time

4 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Experimental and emerging therapies for sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Cachectin: more than a tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

The tumor necrosis factor ligand and receptor families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Detection of circulating tumor necrosis factor after endotoxin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Cachectin and tumour necrosis factor as two sides of the same biological coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Activation of coagulation after administration of tumor necrosis factor to normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Role of Interferon- in Experimental Gram-Negative Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

TREM-1 amplifies inflammation and is a crucial mediator of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Interleukin 10 protects mice from lethal endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Prognostic value of MIP-1 alpha, TGF-beta 2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Arrest of endotoxin-induced hypotension by transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Neutrophil-mediated tissue injury and its modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Granulocyte colony-stimulating factor improves host defense to resuscitated shock and polymicrobial sepsis without provoking generalized neutrophil-mediated damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Filgrastim in patients with pneumonia and severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1061

10.1517/13543784.11.8.1061

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference